Public Forum
Default group for all members. Biological family sometimes get you down? Come join your logical family!
Organizers:
- Organized by
-
-
Skin cancer on my nose.
-
Skin cancer on my nose.
I was diagnosed with basal cell on my nose 30 years ago. My dermatologist decided not to do no surgery but to try a new cream called Aldera cream. This creamed worked but now 30 years later a biopsy shows the cancer has returned. The dermatologist wants to do the Mo surgery on my nose.. has anyone tried DMSO to treat skin cancer? I’m so afraid of the Mo surgery since the cancer is on the end of my nose.. any comments or experience you’ve had would be greatly appreciated!
Thank you!
-
4 Replies
-
Hi @jackie so sorry that you have this diagnosis. I am going to move this over to the public group, that’s where we have the most engagement.
-
Jackie for starters have you downloaded and read any of our Free Cancer resources, perhaps start with “Repurposed Drugs for Cancer” https://imahealth.org/approach-repurposed-drugs-for-cancer/
-
A note and antidotal experience, not medical advice, from me. After the 2024 conference, I chatted to an oncologist about my brother who kept getting recurring skin cancers cut out… she suggested that my brother started using ivermectin, creating a paste with distilled water that he could rub onto the areas of concern. She had seen lots of patients using this with success. She did not give me exact measures, but suggested he keep a paste in the b bathroom and each time he washed his hands to apply a bit of the paste. Up to date… this is working.
-
There are emerging evidence and studies that using methylene blue and near infrared light in combination can treat skin cancer. I have both of these at home and if I were to be diagnosed with skin cancer it would be my first stop, mostly because it is so easy to do. I’ve already fixed conditions that appeared on my skin (I had posted photos previously of before and after) and without any diagnosis of what it was.
Key Emerging Evidence
– Systematic Review (2023, Frontiers in Pharmacology): Reviewed 10 preclinical studies and found that MB-PDT reduced tumor size in models of melanoma, colorectal carcinoma, and squamous cell carcinoma. Effectiveness increased when MB was delivered via nanoparticles or liposomes, which improved penetration and stability.
– Nanotechnology Approaches (2023, Pharmaceutics): Encapsulating MB in nanoparticles enhanced skin penetration and phototoxicity against squamous cell carcinoma cells. ROS generation and cell death were significantly higher when MB was combined with red light.
– Mechanistic Insights (2025 review): MB-PDT in melanoma cells triggers mitochondrial dysfunction, caspase activation, and apoptosis. In ovarian and glioblastoma models, MB also reversed the Warburg effect (shifting metabolism back toward oxidative phosphorylation), which may slow cancer growth.
– Clinical Context (WebMD, NCI): Photodynamic therapy is already FDA-approved for actinic keratosis, basal cell carcinoma, and Bowen’s disease using other photosensitizers. MB is being studied as a potentially safer, cheaper, and more effective alternative, but large-scale clinical trials are still lacking
Log in to reply.